Datamatics Partners with Alkermes to develop Cancer Drugs

Datamatics has entered into a strategic partnership with Alkermes, a global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The partnership is focused on enhancing Alkermes’ patient support services for people prescribed Alkermes medicines.

As part of this collaboration, which began with a competitive procurement process during which Datamatics was selected; Datamatics has deployed a remote patient coordinator service staffed with a team of individuals with healthcare experience to support patients in accessing their medicines and reminding them of their appointments. Datamatics is also helping modernize existing systems and processes to enable the Alkermes’ Patient Access Services team to enhance the customer experience.

Sandeep Arora, EVP and Head of Digital Experiences, Datamatics said, “We are happy to be part of Alkermes’ expansion journey and look forward to a long-term partnership. We at Datamatics have been helping clients globally by augmenting their support teams using customized process automation and AI/ML technology. We enable enterprises to go ‘Deep in Digital’ to improve their productivity, boost competitive advantage and deliver customer experience the way they want it.”